AC
MRK icon

Armistice Capital’s Merck MRK Stock Holding History

Armistice Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-324,039
Closed -$29.1M – 244
2025
Q1 		$29.1M Buy
+324,039
New +$30.3M 0.44% 44
2024
Q4 		– Sell
-182,794
Closed -$20.8M – 280
2024
Q3 		$20.8M Buy
+182,794
New +$21.7M 0.33% 59
2020
Q4 		– Sell
-549,152
Closed -$43.5M – 118
2020
Q3 		$43.5M Buy
549,152
+171,872
+46% +$13.5M 1.58% 17
2020
Q2 		$27.8M Buy
377,280
+62,880
+20% +$4.73M 1.22% 32
2020
Q1 		$23.1M Buy
314,400
+230,560
+275% +$18.1M 1.43% 26
2019
Q4 		$7.28M Sell
83,840
-58,688
-41% -$4.82M 0.42% 61
2019
Q3 		$11.4M Buy
+142,528
New +$11.4M 0.76% 39
2019
Q2 		– Sell
-94,320
Closed -$7.59M – 74
2019
Q1 		$7.59M Buy
+94,320
New +$7.05M 0.42% 45

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital's MRK Position: Q2 2025 in Review

Armistice Capital sold out of Merck (MRK) in Q2 2025, closing a stake of 324,039 shares — an estimated $29.1M sold.

Armistice Capital first reported a position in MRK in Q1 2019 and held it in 8 quarters. The position peaked at $43.5M in Q3 2020. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Armistice Capital reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 324,039 Merck shares in Q2 2025, an estimated $29.1M.
  • Armistice Capital first reported a position in Merck in Q1 2019 and held it in 8 quarters.
  • Armistice Capital's Merck position peaked at $43.5M in Q3 2020.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.